Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Written by ClinicalTrials.gov

Category: Joint Diseases

Published: 12 June 2013

Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib 5 mg BID; Drug: Tofacitinib 10 mg BID; Drug: Adalimumab; Drug: Placebo; Drug: Placebo
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified September 2013

Details: Last Updated: 12 June 2013

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies